Utrecht, August 25th, 2021 – In addition to the 2020 investment of EIT Health, MRIguidance has now raised $1.25 Million from the American venture capital firm Mammoth Scientific. This investment will allow MRIguidance to continue the company’s growth path. After market entry in Europe in the beginning of 2021, MRIguidance will use the new funds to prepare for market roll-out in the U.S.
Growth
BoneMRI for the spine is expected to get market access in Europe later this year. Tommy Martin, CEO of Mammoth Scientific said that this spine application specifically caught the attention of Mammoth Scientific. “We were made aware of MRIguidance through different spine surgeons from our network. We believe BoneMRI has the potential to be a game changing innovation in radiology and spine surgery. As such, MRIguidance is a perfect addition to our portfolio, and we look forward to working with the team.”
Mammoth Scientific
Mammoth Scientific, LLC is a U.S. venture capital firm that focuses on providing financing to innovative health science and technology companies. Mammoth Scientific’s leadership consists of successful physician entrepreneurs and experienced investment managers. “With Mammoth [Scientific] we not only have additional funding for our company, but also an experienced team with an impressive and relevant network in the spine world in the U.S.,” says Roel Raatgever, CEO of MRIguidance. “The team at Mammoth [Scientific] can help us with things like FDA approval and CMS reimbursement. I am very happy to have Mammoth [Scientific] on board.”
BoneMRI in the US
Earlier this year MRIguidance was selected by EIT Health for their Bridgehead Global Program. For MRIguidance this program consists of a grant and support to gain traction with BoneMRI in the U.S. Together with the recent Mammoth Scientific investment, the program will strengthen MRIguidance’s position in the U.S. MRIguidance plans to raise additional funds to scale-up commercial efforts in Europe and the U.S.
_______________
Mammoth Scientific, Mammoth Private Capital Health and Tech Fund, the Mammoth logo, and the tagline “Invest Beyond the Ordinary” are trademarks of Mammoth Scientific, LLC and are protected by trademark laws of the United States and other countries. All other product and company names are trademarks or registered trademarks of their respective companies.
Venture fund management provided by Mammoth Scientific, LLC, an Exempt Reporting Adviser. Private capital platform services provided by The Securities Group, LLC dba Mammoth Research. Member FINRA/SIPC. Securities offered by Mammoth Scientific have not been registered under the Securities Act of 1933, as amended or the securities laws of any state or other jurisdictions in reliance upon exemptions from registration provided by the Securities Act and Regulation D Rule 506(c) and comparable exemptions.
Mammoth Scientific is an investment advisor to certain venture capital funds and files as an exempt reporting advisor, but that status does not imply a certain level of skill or training.
